百诚医药(301096.SZ)下属杭州觅鹏拟1500万元参投合伙企业 布局生物医药、硬科技等战略新兴产业

Core Viewpoint - Baicheng Pharmaceutical (301096.SZ) plans to participate in the subscription of shares in West Lake Innovation (Hangzhou) Venture Capital Partnership, focusing on investment in strategic emerging industries such as biomedicine and hard technology [1] Group 1 - The company will invest 15 million yuan through its controlled entity, Hangzhou Mipeng Enterprise Management Partnership [1] - The partnership aims to target early-stage, small to medium-sized, and growth-stage enterprises for investment opportunities [1]